Greg Cadelina

428 total citations
5 papers, 297 citations indexed

About

Greg Cadelina is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Greg Cadelina has authored 5 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Physiology. Recurrent topics in Greg Cadelina's work include Liver Disease and Transplantation (2 papers), Peptidase Inhibition and Analysis (2 papers) and Protein Degradation and Inhibitors (2 papers). Greg Cadelina is often cited by papers focused on Liver Disease and Transplantation (2 papers), Peptidase Inhibition and Analysis (2 papers) and Protein Degradation and Inhibitors (2 papers). Greg Cadelina collaborates with scholars based in United States, Hungary and Spain. Greg Cadelina's co-authors include Roberto J. Groszmann, Vijay H. Shah, Reiner Wiest, Guillermo García‐Cardeña, William C. Sessa, Rafael Esteban, Rosa Segura, Antonio Herrero, Jaime Guardia and Juan Carlos López-Talavera and has published in prestigious journals such as PLoS ONE, The American Journal of Gastroenterology and American Journal of Physiology-Gastrointestinal and Liver Physiology.

In The Last Decade

Greg Cadelina

4 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Greg Cadelina United States	3	131	130	93	67	59	5	297
Sherry Dadsetan Spain	9	182 1.4×	55 0.4×	125 1.3×	110 1.6×	64 1.1×	9	439
Wenjing Xian China	8	42 0.3×	41 0.3×	67 0.7×	119 1.8×	45 0.8×	10	311
Dragana Rajcic Austria	9	46 0.4×	88 0.7×	169 1.8×	122 1.8×	42 0.7×	18	349
Navine Nasser‐Ghodsi United States	9	93 0.7×	127 1.0×	56 0.6×	68 1.0×	108 1.8×	19	320
Haruyo Hickey Australia	9	25 0.2×	167 1.3×	39 0.4×	192 2.9×	36 0.6×	13	378
I. Y. Liang Hong Kong	11	76 0.6×	97 0.7×	85 0.9×	49 0.7×	73 1.2×	23	348
Grace Auld United Kingdom	3	153 1.2×	46 0.4×	170 1.8×	63 0.9×	51 0.9×	3	370
Katsuyoshi Higashi Japan	7	33 0.3×	64 0.5×	100 1.1×	221 3.3×	71 1.2×	22	443
G Annoni Italy	6	36 0.3×	108 0.8×	36 0.4×	84 1.3×	29 0.5×	15	298
W. I. Bry United States	7	20 0.2×	147 1.1×	39 0.4×	152 2.3×	153 2.6×	15	447

Countries citing papers authored by Greg Cadelina

Since Specialization

Citations

This map shows the geographic impact of Greg Cadelina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Cadelina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Cadelina more than expected).

Fields of papers citing papers by Greg Cadelina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Cadelina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Cadelina. The network helps show where Greg Cadelina may publish in the future.

Co-authorship network of co-authors of Greg Cadelina

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Cadelina. A scholar is included among the top collaborators of Greg Cadelina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Cadelina. Greg Cadelina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Smith, Katie, Jennifer Pizzano, Mark Bookbinder, et al.. (2025). Abstract B107: Preclinical activity of ARV-806, a PROTAC KRAS G12D degrader. Molecular Cancer Therapeutics. 24(10_Supplement). B107–B107.

2.

Smith, Kathryn E., Peter T. Nower, Jennifer Pizzano, et al.. (2023). Abstract PR09: KRAS-targeted PROTAC degraders are broadly efficacious against KRAS-dependent tumor models. Molecular Cancer Research. 21(5_Supplement). PR09–PR09. 2 indexed citations

3.

Wes, Paul D., Amy Easton, John Corradi, et al.. (2014). Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease. PLoS ONE. 9(8). e106050–e106050. 84 indexed citations

4.

Genescà, Joan, Antonio Herrero, Rosa Segura, et al.. (1999). Interleukin-6, Nitric Oxide, and the Clinical and Hemodynamic Alterations of Patients With Liver Cirrhosis. The American Journal of Gastroenterology. 94(1). 169–177. 97 indexed citations

5.

Shah, Vijay H., Reiner Wiest, Guillermo García‐Cardeña, et al.. (1999). Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension. American Journal of Physiology-Gastrointestinal and Liver Physiology. 277(2). G463–G468. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact